Uncontrolled Hypertension: Clinical Trials

7 trials for Uncontrolled Hypertension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 unknown, 1 withdrawn. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 3, Recruiting 2, Unknown 1, Withdrawn 1
Phase 21Withdrawn 1

Follow Uncontrolled Hypertension: new trials by email Literature Review of Uncontrolled Hypertension trials Research Report on Uncontrolled Hypertension

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase IIIb Study to Investigate the Effect of Baxdrostat in Chinese Participants With Uncontrolled Hypertension.
baxdrostat 2mg, Placebo 2mg - Uncontrolled Hypertension
Phase 3RecruitingAstraZeneca2862026-09-172026-10-15
A Study to Evaluate the Efficacy and Safety in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
SAL0120, Placebo - Uncontrolled Hypertension, Resistant Hypertension
Phase 3CompletedShenzhen Salubris Pharmaceuticals Co., Ltd.2562024-10-292026-08-27
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
Baxdrostat, Placebo - Uncontrolled Hypertension, Resistant Hypertension
Phase 3CompletedAstraZeneca3262024-04-082026-04-21
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
Baxdrostat, Placebo - Uncontrolled Hypertension, Resistant Hypertension
Phase 3CompletedAstraZeneca7962023-11-222026-11-03
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
Antihypertensive algorithm, Standard of care - Chronic Kidney Disease(CKD), Uncontrolled Hypertension
Phase 3RecruitingUniversity Hospital, Tours7202023-03-282026-08-03
Adrenal Artery Ablation for Uncontrolled Hypertension
Selective endovascular chemical ablation of adrenal gland, Traditional triple antihypertensive treatment - Uncontrolled Hypertension
Phase 3UnknownThird Military Medical University402018-08-012018-09-06
Rapid Renal Sympathetic Denervation for Resistant Hypertension II
Renal Denervation (OneShot™ Renal Denervation System) - Resistant Hypertension, Uncontrolled Hypertension
Phase 2 / Phase 3WithdrawnMedtronic Endovascular2013-09-012015-08-18

Narrower conditions

Hypertension (2)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Vascular Diseases (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Standard of Care (1)

Sponsors

AstraZeneca (3)  ·  Medtronic Endovascular (1)  ·  Shenzhen Salubris Pharmaceuticals Co., Ltd. (1)  ·  Third Military Medical University (1)  ·  University Hospital, Tours (1)

Countries

China (4)  ·  Argentina (2)  ·  Australia (2)  ·  France (2)  ·  India (2)  ·  Italy (2)  ·  Japan (2)  ·  South Korea (2)  ·  Turkey (Türkiye) (2)  ·  Vietnam (2)  ·  Austria (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)

Top investigators

Dierk Scheinert, MD (1)  ·  Guiseppe Mancia, MD (1)

Results publications

PMID 40850955, PMID 39138914, PMID 40888730, PMID 42754276

NIH funding

2023 (1)